Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for BioMarin Pharmaceutical in a ...
Zacks Research cut their Q4 2026 earnings per share (EPS) estimates for shares of Ubiquiti in a report issued on Wednesday, ...
Opinion
4dOpinion
Zacks Investment Research on MSNTop Research Reports for Bank of America, Accenture & ServiceNowThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...
(TSQ) on Monday reported earnings of $24.6 million in its fourth quarter. The Purchase, New York-based company said it had net ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.
1h
Zacks Investment Research on MSNStrength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?TG Therapeutics TGTX shares soared 10.2% in the last trading session to close at $40.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...
ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $51.2 million in its fourth quarter. On a per-share basis, the Rockville, Maryland-based company said ...
Gogo Inc. (GOGO) on Friday reported a loss of $28.2 million in its fourth quarter. On a per-share basis, the Broomfield, Colorado-based company ...
For the year, the company reported a loss of $41.1 million, or 22 cents per share. Revenue was reported as $698.8 million. For the current quarter ending in March, EverCommerce said it expects revenue ...
SOUTH SAN FRANCISCO, Calif. (AP) — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results